Health Care Use by a Population-Based Cohort of Children With Inflammatory Bowel Disease

Harminder Singh1, Zoann Nugent2, Laura E Targownik3

  • 1IBD Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada; Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Insights

Children with inflammatory bowel disease (IBD) experienced more gastrointestinal visits years before diagnosis, suggesting delayed diagnosis. Surgery rates for pediatric IBD are decreasing.

Area of Science:

  • Pediatric Gastroenterology
  • Epidemiology
  • Health Services Research

Background:

  • Limited population-based data exist on healthcare utilization by children with inflammatory bowel disease (IBD).
  • Understanding healthcare patterns is crucial for improving diagnosis and management of pediatric IBD.

Purpose of the Study:

  • To investigate healthcare utilization in children diagnosed with IBD.
  • To compare healthcare use before and after diagnosis between children with and without IBD.
  • To analyze trends in IBD treatment and surgical outcomes.

Main Methods:

  • A population-based cohort study identified 651 children with IBD and 5950 controls from the University of Manitoba IBD Epidemiology Database.
  • Data on IBD type, diagnosis era, comorbidities, healthcare visits, medication use, and surgeries were extracted and analyzed.
  • Follow-up was conducted for 6419 person-years for children with IBD and 53,875 person-years for controls.

Main Results:

  • Children with IBD had more gastrointestinal symptom-related visits in the four years preceding diagnosis compared to controls.
  • Increased physician encounters for psychosocial diagnoses were observed around the time of IBD diagnosis.
  • Corticosteroid use within a year post-diagnosis was 56%, with no change over time.
  • Eight-year colectomy rates for ulcerative colitis and resective surgery for Crohn's disease were lower in children diagnosed after 2002.

Conclusions:

  • Children with IBD show increased gastrointestinal healthcare visits years before diagnosis, suggesting potential diagnostic delays.
  • Surgical intervention rates are declining in pediatric IBD patients.
  • These findings highlight the need for earlier IBD recognition in children.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
2
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
4
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.6K
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
1